[go: up one dir, main page]

DE60334499D1 - Verfahren zur erhöhung der ausbreitung von b-zellen - Google Patents

Verfahren zur erhöhung der ausbreitung von b-zellen

Info

Publication number
DE60334499D1
DE60334499D1 DE60334499T DE60334499T DE60334499D1 DE 60334499 D1 DE60334499 D1 DE 60334499D1 DE 60334499 T DE60334499 T DE 60334499T DE 60334499 T DE60334499 T DE 60334499T DE 60334499 D1 DE60334499 D1 DE 60334499D1
Authority
DE
Germany
Prior art keywords
cells
increasing
methods
spread
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334499T
Other languages
English (en)
Inventor
Ginette Serrero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A&G Pharmaceutical Inc
Original Assignee
A&G Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A&G Pharmaceutical Inc filed Critical A&G Pharmaceutical Inc
Application granted granted Critical
Publication of DE60334499D1 publication Critical patent/DE60334499D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DE60334499T 2003-02-26 2003-12-17 Verfahren zur erhöhung der ausbreitung von b-zellen Expired - Lifetime DE60334499D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44959303P 2003-02-26 2003-02-26
PCT/US2003/040111 WO2004078782A1 (en) 2003-02-26 2003-12-17 Methods for increasing the proliferation of b cells

Publications (1)

Publication Number Publication Date
DE60334499D1 true DE60334499D1 (de) 2010-11-18

Family

ID=32962489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334499T Expired - Lifetime DE60334499D1 (de) 2003-02-26 2003-12-17 Verfahren zur erhöhung der ausbreitung von b-zellen

Country Status (9)

Country Link
US (1) US7651854B2 (de)
EP (1) EP1601687B1 (de)
JP (1) JP4488903B2 (de)
AT (1) ATE483724T1 (de)
AU (1) AU2003297217B2 (de)
CA (1) CA2517140C (de)
DE (1) DE60334499D1 (de)
ES (1) ES2369695T3 (de)
WO (1) WO2004078782A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215445A1 (en) 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US20100111928A1 (en) * 1997-05-23 2010-05-06 A & G Pharmaceutical, Inc. Methods and kits for diagnosis tumorgenicity
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
EP1601687B1 (de) 2003-02-26 2010-10-06 A & G Pharmaceuticals, Inc. Verfahren zur erhöhung der ausbreitung von b-zellen
AU2004261260B2 (en) 2003-08-01 2011-01-27 A & G Pharmaceuticals, Inc. Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
GB0502046D0 (en) 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
DK2687223T4 (da) 2006-05-30 2025-02-17 Mayo Found Medical Education & Res Påvisning og behandling af demens
EP2687223B2 (de) * 2006-05-30 2024-11-20 Mayo Foundation For Medical Education And Research Erkennung und Behandlung von Demenz
DE102007033359B4 (de) * 2007-07-16 2010-12-02 Johann Wolfgang Goethe-Universität Frankfurt am Main Verwendung eines Granulins oder einer Granulin-ähnlichen Verbindung zur Therapie oder Prophylaxe von chronischen Schmerzen
US20160075766A1 (en) 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
HK1220727A1 (zh) * 2014-05-19 2017-05-12 F. Hoffmann-La Roche Ag 使用绵羊b细胞产生抗体的方法及其用途
CN115078233A (zh) * 2022-07-21 2022-09-20 合肥源恩生物技术有限公司 一种利用流式细胞术检测细胞功能的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416192A (en) 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
WO1993015195A1 (en) 1992-02-03 1993-08-05 Samuel Solomon Granulins from leukocytes
AU6234194A (en) * 1993-01-15 1994-08-15 Board Of Regents, The University Of Texas System High molecular weight b-cell growth factor: interleukin-14
US6720159B1 (en) * 1997-12-16 2004-04-13 A&G Pharmaceutical, Inc. 88KDA tumorigenic growth factor and antagonists
US6881548B2 (en) 1997-05-23 2005-04-19 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
US20030215445A1 (en) * 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US6309826B1 (en) * 1997-05-23 2001-10-30 Ginette Serrero 88kDa tumorigenic growth factor and antagonists
US7091047B2 (en) * 1997-05-23 2006-08-15 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity
MXPA03001245A (es) * 2000-08-11 2003-05-27 Wyeth Corp Metodo para el tratamiento del carcionma positivo para receptores de estrogeno.
AU2002213084A1 (en) 2000-10-11 2002-04-22 Avalon Pharmaceuticals Cancer-linked genes as targets for chemotherapy
US7411045B2 (en) 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
EP1601687B1 (de) 2003-02-26 2010-10-06 A & G Pharmaceuticals, Inc. Verfahren zur erhöhung der ausbreitung von b-zellen
WO2005000207A2 (en) 2003-05-30 2005-01-06 Medimmune, Inc. Pcdgf receptor antibodies and methods of use thereof
EP1644038A2 (de) * 2003-06-23 2006-04-12 A & G Pharmaceuticals, Inc. Zusammenetzungen und verfahren zur wiederherstellung der emfpindlichkeit von tumorzellen auf eine antitumorale therapie und einleitung von apoptose
AU2004261260B2 (en) * 2003-08-01 2011-01-27 A & G Pharmaceuticals, Inc. Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
WO2006044566A2 (en) * 2004-10-13 2006-04-27 A & G Pharmaceutical, Inc. Autocrine growth factor receptors and methods

Also Published As

Publication number Publication date
CA2517140C (en) 2013-12-10
EP1601687A1 (de) 2005-12-07
US20070015225A1 (en) 2007-01-18
JP2006524484A (ja) 2006-11-02
ES2369695T3 (es) 2011-12-05
AU2003297217A1 (en) 2004-09-28
WO2004078782A1 (en) 2004-09-16
ATE483724T1 (de) 2010-10-15
AU2003297217B2 (en) 2010-01-07
EP1601687B1 (de) 2010-10-06
EP1601687A4 (de) 2006-07-26
CA2517140A1 (en) 2004-09-16
US7651854B2 (en) 2010-01-26
JP4488903B2 (ja) 2010-06-23

Similar Documents

Publication Publication Date Title
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE60336901D1 (de) Chinazolinon modulatoren von nukleinrezeptoren
DE602004013492D1 (de) Verfahren und Vorrichtung zur Spamentdeckung
DE60141950D1 (de) Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
DE602004027472D1 (de) Verbessertes verfahren zum wickeln von z-filtermedien
DE60336059D1 (de) Verfahren zu deren verwendung
DE60334499D1 (de) Verfahren zur erhöhung der ausbreitung von b-zellen
ATE506456T1 (de) Verfahren zur behandlung von lentivirusinfektionen
ATE458191T1 (de) Verfahren zur selektion von partikeln
DE60324994D1 (de) Verfahren und Vorrichtung zur Verhinderung der Ausbreitung von böswilligen Programmkode
DE60333768D1 (de) Verfahren und vorrichtung zum erweitern der fuktionalität einer mobilplattform durch verwendung von plug-in-software
DE60128159D1 (de) Vorrichtung zur reformierung von Brennstoff
ATE366923T1 (de) Vorrichtung zur referenzierung von fluoreszenzsignalen
DK1604203T3 (da) Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
ATE426858T1 (de) System und verfahren zum erkennen von bísartigem code
DE602004016422D1 (de) Verfahren und Vorrichtung zur Prüfung von Halbleiterelementen
DE602004021994D1 (de) Vorrichtung, Verfahren und Software zur Verfolgung von Gegenständen
EP1589998A4 (de) Verwendung von säuger-zytokin; verwandte reagenzien
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
ATE507209T1 (de) Referenzstandard zur charakterisierung von rosuvastatin
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE602004024667D1 (de) Verstärkervorrichtung, verfahren und system
ATE347913T1 (de) Verfahren zur identifizierung von wächter- lymphknoten
DE60216416D1 (de) Verfahren zum nachweis von chloralhydrat in dichloressigsäure
DE10321436B8 (de) Vorrichtung zur Erzeugung von Kräften

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 20099 HAMBURG